Package Leaflet: Information for the User
Gabapentina Teva-ratiopharm 100 mg Hard Capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Gabapentina Teva-ratiopharm belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long-lasting pain caused by damage to the nerves).
The active substance in Gabapentina Teva-ratiopharm is gabapentin.
Gabapentina Teva-ratiopharm is used to treat:
Do not take Gabapentina Teva-ratiopharm
Warnings and precautions
Tell your doctor or pharmacist before taking gabapentin
Dependence
Some people may develop dependence (need to keep taking the medicine) on gabapentin. They may have withdrawal symptoms when they stop taking gabapentin (see section 3, "How to take Gabapentina Teva-ratiopharm" and "If you stop taking Gabapentina Teva-ratiopharm"). If you are concerned about developing dependence on gabapentin, it is important that you talk to your doctor.
If you experience any of the following signs while taking gabapentin, it may be indicative of dependence.
If you notice any of the above, talk to your doctor to decide on the best course of treatment for you, including when it is appropriate to stop treatment and how to do it safely.
A small number of people taking antiepileptics, such as gabapentin, have had thoughts of harming themselves or suicide. If at any time you have these thoughts, contact your doctor immediately.
Important information about potentially serious reactions
Severe skin reactions have been reported with the use of gabapentin, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug rash with eosinophilia and systemic symptoms (DRESS). Stop taking gabapentin and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
Read the description of these symptoms in section 4 of this leaflet"Contact your doctor immediately if you experience any of the following symptoms after taking this medicine, as they can be serious".
Muscle weakness, tenderness, or pain and especially if you feel unwell or have a fever, could be due to an abnormal breakdown of muscle tissue that can lead to kidney problems and put your life at risk. You may also experience discoloration of the urine and changes in blood test results (significant increase in creatine phosphokinase in the blood). If you experience any of these signs or symptoms, please contact your doctor immediately.
Other medicines and Gabapentina Teva-ratiopharm
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. In particular, tell your doctor (or pharmacist) if you are taking or have recently taken any medicines for seizures, sleep disorders, depression, anxiety, or any other neurological or psychiatric problem.
Medicines containing opioids such as morphine
If you are taking any medicines that contain opioids (such as morphine), tell your doctor or pharmacist, as opioids can increase the effect of gabapentin.
Additionally, the combination of gabapentin with opioids can cause symptoms such as drowsiness, sedation, decreased breathing, or death.
Antacids for indigestion
If you take gabapentin at the same time as antacids containing aluminium or magnesium, the absorption of gabapentin in the stomach may be reduced. It is recommended that gabapentin be taken at least 2 hours after taking an antacid.
Gabapentina Teva-ratiopharm
Taking Gabapentina Teva-ratiopharm with food
This medicine can be taken with or without food.
Pregnancy, breast-feeding, and fertility
Pregnancy
Gabapentin can be used during the first trimester of pregnancy if necessary.
If you are planning to become pregnant or are pregnant or think you may be pregnant, consult your doctor immediately.
If you become pregnant and have epilepsy, it is important that you do not stop taking your medicine without first talking to your doctor, as this can worsen your condition. Worsening of your epilepsy can put both you and your unborn baby at risk.
In a study that reviewed data from women in Nordic countries who took gabapentin in the first 3 months of pregnancy, there was no increased risk of birth defects or problems with brain development (neurodevelopmental disorders). However, babies of women who took gabapentin during pregnancy had a higher risk of low birth weight and premature birth.
Contact your doctor immediately if you become pregnant, think you may be pregnant, or plan to become pregnant while taking gabapentin. Do not suddenly stop taking this medicine, as this can cause your seizures to return, which could have serious consequences for both you and your baby.
If taken during pregnancy, gabapentin may cause withdrawal symptoms in newborns. This risk may be higher when gabapentin is taken with opioid painkillers (such as morphine).
Breast-feeding
Gabapentin, the active substance in this medicine, passes into breast milk. Breast-feeding is not recommended while taking gabapentin, as the effect on newborns is unknown.
Fertility
There are no effects on fertility in animal studies.
Driving and using machines
Gabapentina Teva-ratiopharm may cause dizziness, drowsiness, and fatigue. Do not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is essentially "sodium-free".
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist. Do not take more than the prescribed dose.
Your doctor will determine the dose that is right for you.
Epilepsy, the recommended dose is
Adults and adolescents
Take the number of capsules that your doctor has told you to. Normally, your doctor will gradually increase your dose. The initial dose will generally be between 300 and 900 mg per day. From then on, the dose may be increased, as prescribed by your doctor, up to a maximum dose of 3600 mg per day, divided into three separate doses, for example, one in the morning, one at noon, and one in the evening.
Use in children
Children aged 6 years and older
Your doctor will decide the dose to give to your child based on the child's weight. Treatment will begin with a low initial dose that will be gradually increased over approximately 3 days. The usual dose to control epilepsy is 25-35 mg/kg/day. The dose is normally given in three divided doses per day, usually one in the morning, one at noon, and one in the evening.
Gabapentin is not recommended for use in children under 6 years of age.
Peripheral neuropathic pain, the recommended dose is
Adults
Take the number of capsules that your doctor has told you to. Normally, your doctor will gradually increase your dose. The initial dose will generally be between 300 and 900 mg per day. From then on, the dose may be increased, as prescribed by your doctor, up to a maximum dose of 3600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one in the evening.
If you have kidney problems or are receiving haemodialysis treatment
Your doctor may prescribe a different dosing schedule and/or different doses if you have kidney problems or are receiving haemodialysis treatment.
If you are an elderly patient (over 65 years of age)
You should take the normal dose of gabapentin, unless you have kidney problems. Your doctor may prescribe a different dosing schedule or different doses if you have kidney problems.
If you think that the effect of this medicine is too strong or too weak, tell your doctor or pharmacist as soon as possible.
Method of administration
Gabapentina Teva-ratiopharm is taken by mouth.
Always swallow the capsules whole with a sufficient amount of water.
Gabapentina Teva-ratiopharm can be taken with or without food.
Continue taking gabapentin until your doctor tells you to stop.
If you take more Gabapentina Teva-ratiopharm than you should
Doses higher than those recommended may cause an increased risk of side effects, including loss of consciousness, dizziness, double vision, difficulty speaking, numbness, and diarrhea.
In case of overdose or accidental ingestion, contact your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken, or go to the emergency department of the nearest hospital if you take more gabapentin than your doctor prescribed. Take any capsules that you have not taken, along with the packaging and leaflet, so that the hospital can easily identify the medicine you have taken.
If you forget to take Gabapentina Teva-ratiopharm
If you forget to take a dose, take it as soon as you remember, unless it is time for your next dose. Do not take a double dose to make up for forgotten doses.
If you stop taking Gabapentina Teva-ratiopharm
Do not stop taking gabapentin suddenly. If you want to stop taking gabapentin, talk to your doctor first. Your doctor will tell you how to proceed. If you are going to stop treatment, it should be done gradually over a minimum of one week. You should be aware that you may experience certain side effects, called withdrawal symptoms, after stopping treatment with gabapentin after short or long-term use. These include seizures, anxiety, difficulty sleeping, feeling unwell (nausea), pain, sweating, tremors, headache, depression, abnormal sensation, dizziness, and a general feeling of being unwell. These effects usually occur within the first 48 hours after stopping treatment with gabapentin. If you experience this withdrawal syndrome, you should contact your doctor.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Stop taking gabapentina and seek immediate medical attention if you notice any of these symptoms:
Contact your doctor immediately if you experience any of the following symptoms after taking this medicine, as they can be serious:
These symptoms can be the first signs of a severe reaction. You should be examined by a doctor to decide if you should continue taking gabapentina.
If you are on hemodialysis, inform your doctor if you develop muscle pain and/or weakness.
Other adverse effects include
Very common (may affect more than 1 in 10 patients):
Common (may affect up to 1 in 10 patients):
In addition, in clinical trials in children, the following frequent adverse effects were reported:
sudden movements and aggressive behavior
Uncommon (may affect up to 1 in 100 patients):
Rare (may affect up to 1 in 1,000 patients):
After the marketing of the medicine, the following adverse effects have been reported:
You should know that you may experience certain adverse effects, called withdrawal syndrome, after interrupting short-term or long-term treatment with gabapentina (see "If you stop treatment with Gabapentina Teva-ratiopharm").
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Gabapentina Teva-ratiopharm
Each hard capsule contains 100 mg of gabapentina.
Capsule content: cornstarch, mannitol (E421), talc (E553b)
Capsule shell: gelatin, titanium dioxide (E171), yellow iron oxide (E172), black iron oxide (E172), red iron oxide (E172), purified water, sodium lauryl sulfate.
Printing ink:
Black printing ink: shellac (E904), black iron oxide (E172)
White printing ink: shellac (E904), titanium dioxide (E171)
Appearance of the product and package contents.
Hard capsules (approximately 16 mm in length), with a white opaque body and marked with TV 3494 in black and a light brown cap marked with TV 3494 in white.
It is available in blisters containing 20, 30, 50, 60, 90, 100, or 200 hard capsules, in single-dose precut blisters containing 20x1, 30x1, 50x1, 60x1, 90x1, 100x1, or 200x1 hard capsules, or in bottles with 50, 100, or 200 hard capsules.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Teva B.V.
Swensweg 5,
2031GA Haarlem,
Netherlands
Manufacturer:
Teva Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
or
Teva Operations Poland Sp. z.o.o,
ul. Mogilska 80. 31-546,
Krakow, Poland
or
Teva Nederland BV
Swensweg 5,
2031 GA Haarlem
Netherlands
Local representative:
Teva Pharma, S.L.U.
C/ Anabel Segura, 11 Edificio Albatros B, 1ª planta
28108 Alcobendas (Madrid)
Spain
Date of the last revision of this prospectus: December 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http: //www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/XXXXX/P_XXXXX.html